Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Plos One
|
February 6, 2013
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease
Vadivel Parthsarathy, Paula L McClean, Christian Hölscher, et al.
Plos One
|
April 6, 2019
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
Makiko Shinomoto, Takashi Kasai, Harutsugu Tatebe, et al.
Scientific Reports
|
September 28, 2022
Alzheimer's disease diagnosis by blood plasma molecular fluorescence spectroscopy (EEM)
Ricardo Fernandes Dos Santos, Maria Paraskevaidi, David M A Mann, et al.
Annals of Clinical and Translational Neurology
|
November 20, 2019
Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS
Takashi Kasai, Yuta Kojima, Takuma Ohmichi, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
August 13, 2016
Development & automation of a novel [(18)F]F prosthetic group, 2-[(18)F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide
Olivia Morris, J Gregory, M Kadirvel, et al.
Biochemistry
|
January 21, 2004
Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity
Susan A Moore, Thomas N Huckerby, Gillian L Gibson, et al.
Biochemical and Biophysical Research Communications
|
August 26, 2006
Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda, Sultan A Salem, David Allsop, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 2, 2006
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M A El-Agnaf, Sultan A Salem, Katerina E Paleologou, et al.
The Journal of Biological Chemistry
|
September 6, 2005
Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia
Brian J Tabner, Omar M A El-Agnaf, Stuart Turnbull, et al.
Plos One
|
April 11, 2017
Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease
Takashi Kasai, Masaki Kondo, Ryotaro Ishii, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Plos One
|
February 6, 2013
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease
Vadivel Parthsarathy, Paula L McClean, Christian Hölscher, et al.
Plos One
|
April 6, 2019
Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
Makiko Shinomoto, Takashi Kasai, Harutsugu Tatebe, et al.
Scientific Reports
|
September 28, 2022
Alzheimer's disease diagnosis by blood plasma molecular fluorescence spectroscopy (EEM)
Ricardo Fernandes Dos Santos, Maria Paraskevaidi, David M A Mann, et al.
Annals of Clinical and Translational Neurology
|
November 20, 2019
Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS
Takashi Kasai, Yuta Kojima, Takuma Ohmichi, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
August 13, 2016
Development & automation of a novel [(18)F]F prosthetic group, 2-[(18)F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide
Olivia Morris, J Gregory, M Kadirvel, et al.
Biochemistry
|
January 21, 2004
Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity
Susan A Moore, Thomas N Huckerby, Gillian L Gibson, et al.
Biochemical and Biophysical Research Communications
|
August 26, 2006
Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda, Sultan A Salem, David Allsop, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 2, 2006
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M A El-Agnaf, Sultan A Salem, Katerina E Paleologou, et al.
The Journal of Biological Chemistry
|
September 6, 2005
Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia
Brian J Tabner, Omar M A El-Agnaf, Stuart Turnbull, et al.
Plos One
|
April 11, 2017
Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease
Takashi Kasai, Masaki Kondo, Ryotaro Ishii, et al.
Page
of 7